WallStreetZenWallStreetZen

NASDAQ: XFOR
X4 Pharmaceuticals Inc Earnings & Revenue

XFOR past revenue growth

How has XFOR's revenue growth performed historically?
Company
N/A
Industry
82.81%
Market
19.67%
XFOR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
XFOR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

XFOR earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$128.9M
Current Profit Margin
0%

XFOR Return on Equity

Current Company
-275.4%
Current Industry
16.8%
Current Market
28.2%
XFOR's Return on Equity (-275.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when XFOR announces earnings.

XFOR Return on Assets

Current Company
-85.1%
Current Industry
3.2%
XFOR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

XFOR Return on Capital Employed

Current Company
-137.95%
Current Industry
-42.4%
XFOR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

XFOR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
XFOR$0.00-$120.35M-$128.91M-100.00%N/A
QSI$1.29M-$85.96M-$91.82M+405.91%N/A
LCTX$8.00M-$22.96M-$23.66M+8.94%N/A
ACHV$0.00-$24.00M-$27.32MN/AN/A
IPHA$67.00M-$700.00k-$8.23M-8.70%N/A

XFOR earnings dates

Next earnings date
Aug 8, 2024

X4 Pharmaceuticals Earnings & Revenue FAQ

What were XFOR's earnings last quarter?

On Invalid Date, X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 2024 earnings per share (EPS) of -$0.26, up 62.5% year over year. Total X4 Pharmaceuticals earnings for the quarter were -$51.77 million. In the same quarter last year, X4 Pharmaceuticals's earnings per share (EPS) was -$0.16.

If you're new to stock investing, here's how to buy X4 Pharmaceuticals stock.

What was XFOR's earnings growth in the past year?

As of Q2 2024, X4 Pharmaceuticals's earnings has grown year over year. X4 Pharmaceuticals's earnings in the past year totalled -$128.91 million.

What is XFOR's earnings date?

X4 Pharmaceuticals's earnings date is Invalid Date. Add XFOR to your watchlist to be reminded of XFOR's next earnings announcement.

What was XFOR's revenue last quarter?

On Invalid Date, X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, X4 Pharmaceuticals's revenue was $0.00.

What was XFOR's revenue growth in the past year?

As of Q2 2024, X4 Pharmaceuticals's revenue has grown null year over year. X4 Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.